撤回:使用孟德尔随机化分析和药物标预测来确定乳腺癌的潜在治疗标
Zhulan Huang1, Hongping Zheng1, Haiyu Wang2
1Department of Ultrasound Medicine, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Longgang Maternity and Child Institute of Shantou University Medical College, Shenzhen, China.
Environmental toxicology
|April 6, 2024
概括
这项研究探讨了基因组关联,以寻找新的乳腺癌治疗方法. 研究人员确定了四个有前途的治疗点:UROD,LMO4,HORMAD1和ZSWIM5,为改善患者结果提供了希望.
科学领域:
- 基因组学就是基因组学.
- 在瘤学瘤学.
- 药物基因组学 药物基因组学
背景情况:
- 乳腺癌是女性癌症死亡的主要原因,由于目前的治疗限制和患者耐受性差,需要新的治疗策略.
- 基因组关联研究为确定新的治疗点和了解疾病机制提供了一个有希望的途径.
研究的目的:
- 为了进行乳腺癌的基因组关联探索.
- 通过先进的遗传分析,确定乳腺癌治疗的潜在治疗点.
主要方法:
- 利用了来自芬恩根数据库的全基因组测序数据.
- 综合表达定量特征位点 (eQTL) 数据来自eQTLGen和GTEx联盟.
- 采用基于摘要和两样本的门德尔随机化 (MR) 分析来确定重要的eQTL和治疗目标.
主要成果:
- 从血液样本分析中确定了103个与乳腺癌显著相关的eQTL.
- 过到19个具有潜在治疗意义的候选基因.
- 确定了UROD,LMO4,HORMAD1和ZSWIM5作为乳腺癌的有希望的治疗点.
结论:
- 基因组关联研究可以有效地发现乳腺癌的可行的治疗点.
- UROD,LMO4,HORMAD1和ZSWIM5代表了未来乳腺癌治疗的新目标.
- 这项研究为开发更有效的乳腺癌治疗方法开辟了新的途径.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K


